"Connectivity of laboratory equipment is progressing rapidly. While it started with the possibility to export data from the equipment onto a computer, smart equipment logged into the WiFi now offers cloud-based connectivity and enables customers to monitor, analyze and take action with their equipment. The functionalities and developments differ however between the types of equipment: while with pipettes there is a need to share protocols with colleagues, freezers benefit from preventative maintenance and biological safety cabinets (BSCs) have other reasons to be connected – from energy conservation to process monitoring and workflow support. You will learn how you can get the most out of your connected biological safety cabinet, whether you are a direct user, a lab manager or facility manager.

This webinar covers trends in connected lab equipment, three reasons to connect your biological safety cabinet, current and future capabilities of cloud-based connectivity in BSCs."

"Whether you work in Hematology, Microbiology or are a Generalist you could come across microbes in primary blood smears. Detecting microbes in primary blood is usually a critical value and should trigger additional actions. This webinar will be a review of the most common microbes you could encounter and their diagnostic features. We will discuss clinical factors that could support your diagnosis, limitations to this type of identification, and additional testing that may be recommended. Whether you report these identifications in your facility or refer to other facilities, the ability to recognize microbes in primary blood smears is critical for good patient care.

A certificate of participation will be granted to each participant based on 1.0 contact hours of instruction toward credit."

A webinar sponsored by Astrix 

Date:  Wednesday, January 19, 2021

Time:  1:00 PM EST / 10:00 AM PST

Presenters from ResultWorks – An Astrix Business:

Susan Butler, Vice President, Consulting Services and Operations, ResultWorks

Bob O’Hara, Vice President, Business Development, ResultWorks

Overview:

Clinical development organizations across life sciences have common challenges associated with aging and siloed technologies, changing trial paradigms, and ability to easily access and leverage clinical data assets. As demand for increased efficiency and access to data increase, the historic approach to building solutions within individual clinical development functions continues to create significant issues. This is further compounded by the increase in the number of vendors and partners involved in the process, the variety and volume of clinical data used in analyses, and limited capabilities to leverage emerging technologies. These factors hinder the ability to rapidly analyze clinical and real world data to drive insights and outcomes and bring medicines to patients faster.

Aligning sponsors and stakeholders on a strategy and vision for the future is critical to the transformation and provides strategic direction to the development of the strategy as well as downstream IT portfolio decision making. Ideally, the strategy should enable a data-centric platform-based strategy, ensure core and emerging capabilities are supported through modern technologies and architectures, and deliver a flexible and agile roadmap that drives value based on business priorities.

In this webinar we will discuss:

• Common technology challenges across clinical development
• What is a data centric platform-based approach?
• Capturing business and technical capabilities leading to stakeholder alignment on an actionable clinical technical strategy

"atient Blood Management (PBM) as defined by the Society for the Advancement of Blood Management refers to “the timely application of evidence-based medical and surgical concepts designed to maintain hemoglobin concentration, optimize hemostasis and minimize blood loss in an effort to improve patient outcome”.

Although the World Health Organization endorsed PBM in 2010, many hospitals still seek guidance with the implementation of PBM in clinical routine which goes beyond blood transfusion.

A review of the literature demonstrates that the role of the clinical laboratory in the multidisciplinary concept of PBM is underrepresented.

The speaker will explore the important role of the clinical laboratory and how it can impact each of the PBM pillars: from detecting anemia and iron deficiency to reducing blood loss."

"Legalization of medical and recreational cannabis and hemp has led to an expansion of potency testing needs. Routine testing workflows are now benefiting from the addition of an increasing number of minor and niche cannabinoids to keep up with the diverse range of cultivars and formulations reaching the market. While five primary cannabinoids, Δ9-THC, CBD, THCA, CBDA and CBN are the most common and abundant, new indications are continuously being explored with dozens of other cannabinoids.

In addition, the increasing demands on testing laboratories has created the need for a fast, efficient and accurate quantification method for an increasing number of cannabinoids. In this webinar we will show practical chromatographic separations of 18 cannabinoids with flexibility across HPLC and UHPLC platforms in a simple, isocratic workflow. Potency testing requiring sensitivity and specificity beyond standard workflows will also be discussed.

Attend this webinar to learn about all key aspects of potency analysis ..."

"On December 17, 2021, the United State Environmental Protection Agency (USEPA) published the final Unregulated Contaminants Monitoring Rule 5 (UCMR5). This 5th UCMR will require monitoring of the drinking water entry points of public water systems across the nation for selected Per- and Polyfluoroalkyl substances (PFAS) and Lithium. To assist our water system customers plan for a successful implementation of the UCMR5 requirements, we will project a detailed overview of the Rule requirements, including key milestones, deadlines plus opportunities for efficiency and cost savings."

"The Centers for Medicare & Medicaid Services (CMS) developed Hierarchical Condition Categories (HCCs) to adjust capitated payments for its Medicare Advantage (Part C) plans based on individualized patient risk. The health status of each patient is determined by their diagnoses, which are primarily based on International Statistical Classification of Diseases codes (ICD-10 codes) retrieved from claims data. The HCC risk adjustment methodology is used by all commercial Medicare Advantage plans as well as in the Exchange market. Thus, they are of utmost importance to any health plan or health system providing coverage.

But could the medical laboratory play a role in this process? If so, what?

​Rhodes Group is synonymous with finding new values for medical laboratories through its FOCUS product line. Join us for our most recent developments in our newest application that uses laboratory results to assist in the area of risk adjustment!"